These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17575223)

  • 1. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
    Rolland P; Deen S; Scott I; Durrant L; Spendlove I
    Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
    Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
    Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
    Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic p27 expression is an independent prognostic factor in ovarian cancer.
    Duncan TJ; Al-Attar A; Rolland P; Harper S; Spendlove I; Durrant LG
    Int J Gynecol Pathol; 2010 Jan; 29(1):8-18. PubMed ID: 19952944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
    Duncan TJ; Al-Attar A; Rolland P; Scott IV; Deen S; Liu DT; Spendlove I; Durrant LG
    Clin Cancer Res; 2008 May; 14(10):3030-5. PubMed ID: 18483368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.
    Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J
    Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
    Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
    Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.
    Leffers N; Lambeck AJ; de Graeff P; Bijlsma AY; Daemen T; van der Zee AG; Nijman HW
    Gynecol Oncol; 2008 Sep; 110(3):365-73. PubMed ID: 18571704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer.
    Morabito A; Dozin B; Salvi S; Pasciucco G; Balbi G; Laurent S; Pastorino S; Carli F; Truini M; Bruzzi P; Del Mastro L; Pistillo MP
    Hum Immunol; 2009 Jul; 70(7):492-5. PubMed ID: 19410618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
    Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
    Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB-3 predicts survival in ovarian cancer.
    Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
    J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients.
    de Bruin EC; van de Velde CJ; van Krieken JH; Marijnen CA; Medema JP
    Clin Cancer Res; 2008 Feb; 14(4):1073-9. PubMed ID: 18281539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.
    Levidou G; Korkolopoulou P; Thymara I; Vassilopoulos I; Saetta AA; Gakiopoulou H; Konstantinidou A; Kairi-Vassilatou E; Pavlakis K; Patsouris E
    Int J Gynecol Pathol; 2007 Oct; 26(4):410-7. PubMed ID: 17885491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.
    de Kruijf EM; van Nes JG; Sajet A; Tummers QR; Putter H; Osanto S; Speetjens FM; Smit VT; Liefers GJ; van de Velde CJ; Kuppen PJ
    Clin Cancer Res; 2010 Feb; 16(4):1272-80. PubMed ID: 20145162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of Ca 125 levels during primary therapy.
    Markmann S; Gerber B; Briese V
    Anticancer Res; 2007; 27(4A):1837-9. PubMed ID: 17649781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
    Khouja MH; Baekelandt M; Nesland JM; Holm R
    Int J Gynecol Pathol; 2007 Oct; 26(4):418-25. PubMed ID: 17885492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.